biotx.ai

biotx.ai

Biotx.ai leverages AI-driven causal modeling to predict drug efficacy and streamline drug discovery and development processes. Their proprietary causal genome dataset maps genetic loci to disease risk and biomarker levels, enabling accurate screening and identification of drug indications. With a focus on biopharma and CRO partnerships, they have successfully out-licensed multiple drug assets and facilitated clinical trials, demonstrating significant traction in the biopharmaceutical industry. Their innovative approach positions them as a leader in precision medicine, utilizing large-scale human genetic data to enhance drug development outcomes.